Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi‐, Thiosemicarbazides and 1,3,4‐Oxadiazoles
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202503081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Alexander V Shpatov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Novosibirsk Institute of Organic Chemistry (NIOC), Novosibirsk, Russia. Hauptthemen laut MEDLINE: Semicarbazides, Abietanes, Antineoplastic Agents, Oxadiazoles. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Ministry of Science and Education of Russian Federation.
Abstract (Originalsprache)
A series of novel hybrids of dehydroabietic acid (DHA) with semi‐, thiosemicarbazides, and amino‐1,3,4‐oxadiazoles was synthesized starting from respective thioisocyanates or isocyanates. The cyclodehydrosulfurization of thiosemicarbazides with Hg(OAc) 2 was used as a fast and efficient method to obtain regioisomeric 2‐alkyl(aralkyl, aryl)amino‐5‐terpenyl‐ and 2‐terpenylamino‐5‐alkyl(aralkyl, aryl)‐1,3,4‐oxadiazoles, even in the case of sterically hindered dehydroabietyl derivatives. Several conformationally flexible acylthiosemicarbazide and 2‐amino‐1,3,4‐oxadiazole hybrids exhibited cytotoxicity against HepG2, MCF‐7, and HeLa tumor cell lines that was significantly superior to that of the parent DHA. Among them, 2‐(abieta‐8,11,13‐trien‐18‐oyl)‐ N ‐phenylhydrazincarbothioamide was the most active (GI 50 = 12–17 µM), inhibiting the growth of tumor cells with greater selectivity (SI = 4.6–7.2) than doxorubicin, a positive control. The thiosemicarbazide moiety in the molecules of the acylthiosemicarbazide hybrids was important for the inhibition of the tumor cells’ growth, while its adjacement mode to the terpenyl fragment was tolerant for retaining cytotoxicity. Replacement of the sulfur‐containing thiosemicarbazide moiety with the sulfur–free semicarbazide resulted in the loss of cytotoxic properties. Absorption, distribution, metabolism, and excretion (ADME) parameters of the synthesized hybrids were assessed in silico.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry, Novosibirsk Institute of Organic Chemistry (NIOC), Novosibirsk, Russia.
- Laboratory of Pharmacological Research, Novosibirsk Institute of Organic Chemistry (NIOC), Novosibirsk, Russia.
ORCID-Profile: Alexander V Shpatov
Förderung
- Ministry of Science and Education of Russian Federation
Zitieren
APA
Shpatov, A. V., Zakharova, S. S., Popov, S. A., Meshkova, Y. V., Marenina, M. K., Tolstikova, T. G., & Shults, E. E. (2026). Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi‐, Thiosemicarbazides and 1,3,4‐Oxadiazoles. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202503081
Vancouver
Shpatov AV, Zakharova SS, Popov SA, Meshkova YV, Marenina MK, Tolstikova TG, et al. Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi‐, Thiosemicarbazides and 1,3,4‐Oxadiazoles. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202503081
BibTeX
@article{Shpatov2026,
author = {Shpatov, Alexander V and Zakharova, Sofiya S and Popov, Sergey A and Meshkova, Yulia V and Marenina, Mariya K and Tolstikova, Tatyana G and Shults, Elvira E},
title = {Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi‐, Thiosemicarbazides and 1,3,4‐Oxadiazoles},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202503081}
}
EUVIMED